RHINO BIOTECH Ltd (CIK: 0001278465) EDGAR, Information, Filings... CompaniesBIO.Com

RHINO BIOTECH Ltd

Mailing address
1714 DUCHESS DRIVE, LONGMONT, CO, 80501
Phone
312-265-4165
State location
Anguilla
State of incorporation
N/A
Fiscal year end
December 31
SIC
1311 - (CF Office: Office of Energy & Transportation) CRUDE PETROLEUM & NATURAL GAS
Filings
N/A

RHINO BIOTECH Ltd (CIK: 0001278465) is an American company incorporated in the state of Anguilla. Head office is located at 294 HEYWOOD HOUSE, SOUTH HILL, Anguilla, 1A AI-2640. Work in the industry 1311 - (CF Office: Office of Energy & Transportation) CRUDE PETROLEUM & NATURAL GAS. RHINO BIOTECH Ltd is a public company and trade via Over-The-Counter (OTC).

Old names:

EURASIA ENERGY LTD from 2006-12-Jan to 2021-30-Aug
PACIFIC ALLIANCE VENTURES LTD from 2004-02-Feb to 2005-22-Dec

Owner	Filings	Transaction Date	Type of Owner
Crabtree Graham	0001461682	Sep-10-2008	officer: Chief Financial Officer
Thomas Roger	0001359881	Mar-24-2006	director
King Velda	0001311453	Dec-31-2004	director, officer: President, C.E.O.
Baxter Nicholas W	0001312326	Dec-31-2004	10 percent owner
TUSKEY GERALD R	0001284744	Apr-27-2004	director, officer: C.F.O., Secretary/Treasurer

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by RHINO BIOTECH Ltd

Filings	Format	Description	Filed/Effective	File/Film Number
NT 20-F	Document	Notice under Rule 12b25 of inability to timely file all or part of an annual report of form 20-F Acc-no: 0001213900-24-038695 (34 Act) Size: KB	May-02-2024	000-50608 24904788
NT 20-F	Document	Notice under Rule 12b25 of inability to timely file all or part of an annual report of form 20-F Acc-no: 0001213900-24-038694 (34 Act) Size: KB	May-02-2024	000-50608 24904787
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001213900-23-073379 (34 Act) Size: KB	Sep-05-2023	000-50608 231233533
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001213900-22-024171 (34 Act) Size: KB	May-05-2022	000-50608 22895317
NT 20-F	Document	Notice under Rule 12b25 of inability to timely file all or part of an annual report of form 20-F Acc-no: 0001213900-22-023475 (34 Act) Size: KB	May-03-2022	000-50608 22885725
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001213900-22-022229 (34 Act) Size: KB	Apr-28-2022	000-50608 22865176
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001213900-22-017649 (34 Act) Size: KB	Apr-04-2022	000-50608 22800337
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001213900-22-011935 (34 Act) Size: KB	Mar-14-2022	000-50608 22734674
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001213900-22-002783 (34 Act) Size: KB	Jan-20-2022	000-50608 22541576
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001312326-21-000001 ( Act) Size: 0 KB	Aug-30-2021
20-F	Document	Annual and transition report of foreign private issuers pursuant to sections 13 or 15(d) Acc-no: 0001654954-21-005825 (34 Act) Size: KB	May-17-2021	000-50608 21928987
NT 20-F	Document	Notice under Rule 12b25 of inability to timely file all or part of an annual report of form 20-F Acc-no: 0001654954-21-004950 (34 Act) Size: KB	Apr-30-2021	000-50608 21879305
20-F	Document	Annual and transition report of foreign private issuers pursuant to sections 13 or 15(d) Acc-no: 0001654954-20-004695 (34 Act) Size: KB	Apr-30-2020	000-50608 20834419
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001654954-19-011665 (34 Act) Size: KB	Oct-11-2019	000-50608 191147788
20-F	Document	Annual and transition report of foreign private issuers pursuant to sections 13 or 15(d) Acc-no: 0001654954-19-005860 (34 Act) Size: KB	May-14-2019	000-50608 19821494
NT 20-F	Document	Notice under Rule 12b25 of inability to timely file all or part of an annual report of form 20-F Acc-no: 0001654954-19-005134 (34 Act) Size: KB	May-01-2019	000-50608 19787807
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001654954-18-014151 (34 Act) Size: KB	Dec-20-2018	000-50608 181246186
20-F	Document	Annual and transition report of foreign private issuers pursuant to sections 13 or 15(d) Acc-no: 0001137171-18-000058 (34 Act) Size: KB	May-07-2018	000-50608 18811167
NT 20-F	Document	Notice under Rule 12b25 of inability to timely file all or part of an annual report of form 20-F Acc-no: 0001137171-18-000057 (34 Act) Size: KB	May-02-2018	000-50608 18796703
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001137171-17-000067 (34 Act) Size: KB	Jun-14-2017	000-50608 17909997

Recent 20 filings. View all RHINO BIOTECH Ltd filings

Overall rating 5.0

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

RHINO BIOTECH Ltd overview
RHINO BIOTECH Ltd job
RHINO BIOTECH Ltd stock
RHINO BIOTECH Ltd ownership
RHINO BIOTECH Ltd CEO
RHINO BIOTECH Ltd documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.